Terms: = Colorectal cancer AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280 AND Clinical Outcome
4 results:
1. colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway.
Andreuzzi E; Fejza A; Polano M; Poletto E; Camicia L; Carobolante G; Tarticchio G; Todaro F; Di Carlo E; Scarpa M; Scarpa M; Paulitti A; Capuano A; Canzonieri V; Maiero S; Fornasarig M; Cannizzaro R; Doliana R; Colombatti A; Spessotto P; Mongiat M
J Exp Clin Cancer Res; 2022 Feb; 41(1):60. PubMed ID: 35148799
[TBL] [Abstract] [Full Text] [Related]
2. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon cancer via Inhibiting Immune Tolerance.
Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
[TBL] [Abstract] [Full Text] [Related]
3. 1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
Liu X; Zhou W; Zhang X; Ding Y; Du Q; Hu R
Int J Cancer; 2018 Sep; 143(6):1516-1529. PubMed ID: 29607498
[TBL] [Abstract] [Full Text] [Related]
4. VEGFA gene locus (6p12) amplification identifies a small but highly aggressive subgroup of colorectal cancer [corrected] patients.
Vlajnic T; Andreozzi MC; Schneider S; Tornillo L; Karamitopoulou E; Lugli A; Ruiz C; Zlobec I; Terracciano L
Mod Pathol; 2011 Oct; 24(10):1404-12. PubMed ID: 21743435
[TBL] [Abstract] [Full Text] [Related]
